Lenalidomide-Associated ITP

Lenalidomide is a potent immunomodulatory agent being used increasingly for treatment of hematologic malignancies including multiple myeloma and myelodysplasia. The common toxicities of lenalidomide, including dose-limiting myelosuppression, are well described. However, the immunomodulatory properti...

Descripción completa

Detalles Bibliográficos
Autores principales: Herold, Christina I., Gasparetto, Cristina, Arepally, Gowthami M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420444/
https://www.ncbi.nlm.nih.gov/pubmed/22937309
http://dx.doi.org/10.1155/2011/638020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420444/
https://www.ncbi.nlm.nih.gov/pubmed/22937309
http://dx.doi.org/10.1155/2011/638020

Ejemplares similares